Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

Clinical trial NCT03510208 · RECRUITING

Trial details

NCT number: NCT03510208
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Brain Neoplasm Malignant Glioma

Start date: 2018-05-16
Primary completion: 2026-11-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.